Reactor production of 32P for medical applications: an assessment of 32S(n,p)32P and 31P(n,γ)32P methods

Vimalnath, K.V.; Shetty, Priyalata; Rajeswari, A.; Chirayil, Viju; Chakraborty, Sudipta; Dash, Ashutosh

doi:10.1007/s10967-014-3115-0

Cited by 11 publications

(1 citation statement)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In radiotherapy, 32 P administered through a medium of catheter, wire, and seeds. Phosphorous-32 can be produced in a reactor with a nuclear reaction of 32 S(n,p) 32 P. Phosphorous-32 is β-particle transmitter that generates maximum energy of 1.71 MeV with an average energy of 0.7 MeV and a half-life of 14.2 days 1 . The range of beta particle maximum distance in air is 620 cm in air, 0.8 cm in tissue and 0.6 cm in plexiglass Phosphorous-32 as a beta transmitter has a low linear energy transfer (LET) compared to alpha particles 2 .…”

mentioning

confidence: 99%

Preliminary Study on Production Of 32P – Labeled Phosphate Chromic as A Material for Skin Patch

Rahman¹,

Sarmini²,

Herlina³

et al. 2019

IJPST

View full text Add to dashboard Cite

Keloids are skin disorders or benign tumours that are due to abnormal wound healing in the binding tissue after trauma, inflammation, surgical wounds, or burns. Low activity radioisotopes have shown to be effective in curing or eliminating keloids on the skin. One of these radioisotopes is phosphorus-32 (32 P), a beta (β-) emitter with a half-life of 14.3 days. This radioisotope can also be developed for the treatment of keloid and skin tumours. Currently, the keloid is treated by conventional methods where a filter paper which has been wetted with 32 P in form of its sodium phosphate directly applied on the area of the keloid. However, this method is considered inefficient and less secure. The purpose of this research is to obtain technology for preparing of 32 P-labeled skin patch which is expected to be which will not decompose easily. The first step of this research is to produce 32 P-labeled chromic phosphate (Cr 32 PO 4) colloids, a precursor of skin patch, through condensation which involves oxidation-reduction reaction. In this step, Cr (VI) is reduced to Cr (III) to form Cr 32 PO 4 with a particle size of <1 μm. These particles (Cr 32 PO 4) are expected to evenly distributed when mixed with silicon to form skin patch. The reaction gave a yield of 97,8%. The results of characterization show that the prepared Cr 32 PO 4 colloids have a particle size of > 1μm. Further study needs to be performed in due time in order to have Cr 32 PO 4 colloids with suitable particle size.

show abstract

mentioning

confidence: 99%